The German Group plans to eliminate jobs, especially in its agrochemical branch, a total of 4100 jobs. As in the field of non-prescription drug production (1,100) and in research and development (1,250).
The chemist and pharmacist giants say they will eliminate more than 10% of their power, which will enable him to save 2,600 million euros annually (about $ 3,000 million). In the statement, the group said "a significant number of suppression will be in Germany".
"These changes are indispensable and will set new ground for Bayer, allow him to improve his performance and flexibility," said Werner Baumann, CEO of the group, based in Leverkusen.
Last year, the German company secured 63,000 million dollars (54,000 million euros) to acquire Monsanto, which among other things produces glyphosate, a herbicide charged with health damage.
Just two months later, a court ruling in San Francisco (United States of America) found that Monsanto should warn consumers of cancer risks arising from the glyphosate-based Roundup herbicide.
But earlier this month, the prosecutor agreed to reduce the damage compensation to $ 78 million from the initial $ 289 million. Buying Monsanto, described as the "diabolical marriage" of its sponsors, prompted Bayer to put its agrochemical and pharmaceutical activities at the center of its strategy.
That is why now they want to break away from her sector of animal health, the smallest in the group, and sell two parapharmatic activities, Coppertone (sun cream) and Dr. Scholl (nursing).
The German Group plans to sell its 60-percent stake in Currenti, which operates three chemical plants in Germany.
From a court decision, investors are nervously observing the group. Activists and politicians from the United States and Europe claim that glyphosate is causing cancer, although Bayer notes that no scientific findings have been found.
At the end of last month, the US subsidiary was faced with 9,300 cases associated with glyphosate. But Bauman, the CEO of the group, relies on Monsanto's integration.
Although he admitted it was possible to file multiple lawsuits, he repeated that Bayer "defends with all available means".